ANAVEX LIFE SCIENCES CORP. — Director's Dealing 2021

Aug 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANAVEX LIFE SCIENCES CORP. (AVXL)
CIK: 0001314052
Period of Report: 2021-08-02

Reporting Person: Boenisch Sandra (PFO and Treasurer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-02	Stock Option (Right to Buy)	$18.11	A	40000	Acquired	2031-08-02	Common Stock (40000)	Direct

Footnotes

F1: The options shall vest upon achieving a key enrollment milestone in a late stage clinical study.